SENS Stock Forecast: Senseonics Holdings, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for Senseonics Holdings, Inc. is $16. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 33 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Senseonics Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (83): Analysts have, on balance, been raising their forecasts.
Issuance (9): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
SENS stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on SENS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 10 Nov 2026 | Barclays | Maintains | Equal-Weight | — |
| 10 Nov 2026 | HC Wainwright & Co. | Reiterates | Buy | — |
| 10 Nov 2026 | Mizuho | Maintains | Outperform | — |
| 10 Nov 2026 | Raymond James | Upgrade | Market Perform | — |
| 10 Nov 2026 | Stifel | Reiterates | Hold | — |
| 10 Nov 2026 | TD Cowen | Maintains | Buy | — |
| 27 Oct 2026 | TD Cowen | Reiterates | Buy | — |
| 7 Oct 2026 | Barclays | Initiates | Equal-Weight | — |
| 15 July 2026 | Mizuho | Maintains | Outperform | — |
| 12 May 2026 | HC Wainwright & Co. | Maintains | Buy | — |
| 11 May 2026 | Stifel | Maintains | Hold | — |
| 6 Nov 2025 | HC Wainwright & Co. | Maintains | Buy | — |
| 5 Nov 2025 | Barclays | Maintains | Overweight | — |
| 5 Nov 2025 | TD Cowen | Maintains | Buy | — |
| 27 Aug 2025 | Barclays | Initiates | Overweight | — |
| 15 July 2025 | TD Cowen | Initiates | Buy | — |
| 8 July 2025 | HC Wainwright & Co. | Maintains | Buy | — |
| 10 Apr 2025 | Mizuho | Initiates | Outperform | — |
| 5 Mar 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 15 Nov 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for SENS.
This page is one stock. Monday covers all of them.
SENS appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
SENS vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Senseonics Holdings, Inc. returned +52.2% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
SENS analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 7.3×
- Price / book
- 5.7×
- EV / EBITDA
- —
Cheaper than 15% of US stocks
Cheaper than 15% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 59.1%
- Operating margin
- —
- Net margin
- —
Higher than 72% of US stocks
- Return on equity
- −157.3%
- Return on assets
- −49.9%
- Dividend yield
- —
Higher than 9% of US stocks
Higher than 8% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Senseonics Holdings, Inc. has a market value of $439.3M and an enterprise value of $375.6M.
Revenue in the twelve months to 30 June 2026: $48.5M. The latest quarter grew 117.8% year on year.
Net income over the same four quarters: −$109.4M, a −225.3% net margin.
Free cash flow in the twelve months to 30 June 2026: −$96.8M, after $886K of capital spending.
Senseonics Holdings, Inc. employs 130 people — $373K of revenue per employee.
Data provided by Twelve Data
SENS and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at SENS’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Senseonics Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about SENS
What is the SENS stock price forecast for 2026-2027?
The median 12-month analyst price target for Senseonics Holdings, Inc. is $16, with estimates ranging from $10 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is SENS stock a buy right now?
Of the 8 analysts covering Senseonics Holdings, Inc., 4 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Senseonics Holdings, Inc. 33 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank SENS?
As at 21 Nov 2026, Senseonics Holdings, Inc. ranks 33 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Revisions (83 of 100).
Will SENS stock go up?
No one can know that. What the data says: the median 12-month target from 8 analysts is $16, and Ticker Nerd's factor model ranks Senseonics Holdings, Inc. 33 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the SENS stock forecast for 2030?
No analyst covering Senseonics Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SENS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $20 over the next 12 months.
How has SENS stock performed over the past year?
Senseonics Holdings, Inc. returned +52.2% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Senseonics Holdings, Inc. do?
Senseonics Holdings Inc. is a medical technology company focused on long-term implantable continuous glucose monitoring systems for people with diabetes. Its Eversense product line combines a small under-the-skin sensor, a removable smart transmitter, and a mobile app to provide ongoing glucose readings, alerts, and diabetes management support.
About Senseonics Holdings, Inc.
Senseonics Holdings Inc. is a medical technology company focused on long-term implantable continuous glucose monitoring systems for people with diabetes. Its Eversense product line combines a small under-the-skin sensor, a removable smart transmitter, and a mobile app to provide ongoing glucose readings, alerts, and diabetes management support. The company’s current offerings are designed to serve patients and healthcare providers seeking an alternative to traditional short-duration CGM devices, with products used in the United States and international markets. Senseonics Holdings Inc. operates in the diabetes management and implantable medical device segments, where it plays a specialized role in glucose monitoring technology. Headquartered in Germantown, Maryland, the company is known for its focus on durable, wearable-connected monitoring solutions that support day-to-day diabetes care.
CEO Dr. Timothy T. Goodnow Ph.D. · 130 employees · United States · https://www.senseonics.com